C57BL/6JCya-Cacna1cem1flox/Cya
Common Name:
Cacna1c-flox
Product ID:
S-CKO-01488
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Cacna1c-flox
Strain ID
CKOCMP-12288-Cacna1c-B6J-VA
Gene Name
Product ID
S-CKO-01488
Gene Alias
Cav1.2; Cchl1a1; D930026N18Rik; MBC; MELC-CC
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
6
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Cacna1cem1flox/Cya mice (Catalog S-CKO-01488) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000112793
NCBI RefSeq
NM_001256002
Target Region
Exon 2
Size of Effective Region
~0.8 kb
Detailed Document
Overview of Gene Research
CACNA1C encodes the pore-forming subunit of the CaV1.2 L-type Ca2+ channel, a crucial component in membrane physiology across multiple tissues like the heart, brain, and immune system [1]. This channel is involved in various cellular functions, and the gene's role is of great biological importance in understanding physiological and pathological processes. Genetic models, such as gene knockout (KO) or conditional knockout (CKO) mouse models, can be valuable for studying CACNA1C.
Mutations in CACNA1C can lead to a wide range of disorders. Timothy syndrome (TS), a severe multisystem disorder, is characterized by neurodevelopmental deficits, long-QT syndrome, cardiac arrhythmias, craniofacial abnormalities, and immune deficits [1]. Additionally, CACNA1C-related disorders can present with more selective phenotypes, such as predominantly cardiac or neurological symptoms. Some individuals with heterozygous variants in CACNA1C show neurological manifestations like developmental delays, intellectual disability, autism, hypotonia, ataxia, and epilepsy [2]. Functional studies of missense variants via patch-clamp experiments demonstrated differential effects on channel function in vitro, including loss of function, neutral effect, and gain of function [2]. Large-scale genome-wide association studies have shown that genetic variation in CACNA1C increases the risk for psychiatric disorders, and research has focused on uncovering the underlying biological mechanisms [3]. Meta-analyses suggest that CACNA1C (rs1006737) may be a susceptibility gene for schizophrenia [4]. Pharmacoepidemiological evidence indicates that calcium channel blockers targeting L-type calcium channels (LTCCs) encoded by CACNA1C might have beneficial effects on the onset or course of psychiatric disorders [5]. Also, CACNA1C-rs1006737 polymorphisms are slightly associated with cognitive performance in severe mental disorders [6]. In ovarian cancer, CACNA1C has lower expression in tumor tissues, is an independent risk factor of overall survival, and is associated with immunity [7].
In conclusion, CACNA1C is essential for membrane physiology in multiple tissues. Model-based research, such as KO or CKO mouse models (not directly described in provided references but emphasized as valuable approach), could potentially further clarify its role in various disease areas including multisystem disorders, neurological and psychiatric conditions, and ovarian cancer. Understanding CACNA1C is crucial for unravelling the mechanisms of these diseases and may offer new directions for treatment.
References:
1. Herold, Kevin G, Hussey, John W, Dick, Ivy E. . CACNA1C-Related Channelopathies. In Handbook of experimental pharmacology, 279, 159-181. doi:10.1007/164_2022_624. https://pubmed.ncbi.nlm.nih.gov/36598608/
2. Rodan, Lance H, Spillmann, Rebecca C, Kurata, Harley T, Au, Ping Yee Billie, Shashi, Vandana. 2021. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations. In Genetics in medicine : official journal of the American College of Medical Genetics, 23, 1922-1932. doi:10.1038/s41436-021-01232-8. https://pubmed.ncbi.nlm.nih.gov/34163037/
3. Moon, Anna L, Haan, Niels, Wilkinson, Lawrence S, Thomas, Kerrie L, Hall, Jeremy. . CACNA1C: Association With Psychiatric Disorders, Behavior, and Neurogenesis. In Schizophrenia bulletin, 44, 958-965. doi:10.1093/schbul/sby096. https://pubmed.ncbi.nlm.nih.gov/29982775/
4. Zhu, Dongjian, Yin, Jingwen, Liang, Chunmei, Wang, Yajun, Ma, Guoda. 2019. CACNA1C (rs1006737) may be a susceptibility gene for schizophrenia: An updated meta-analysis. In Brain and behavior, 9, e01292. doi:10.1002/brb3.1292. https://pubmed.ncbi.nlm.nih.gov/31033230/
5. Harrison, Paul J, Husain, Syed M, Lee, Hami, Haerty, Wilfried, Tunbridge, Elizabeth M. 2022. CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiology. In Neuropharmacology, 220, 109262. doi:10.1016/j.neuropharm.2022.109262. https://pubmed.ncbi.nlm.nih.gov/36154842/
6. Novaes de Oliveira Roldan, Ana Cecília, Fernandes Júnior, Luiz Carlos Cantanhede, de Oliveira, Carlos Eduardo Coral, Nunes, Sandra Odebrecht Vargas. 2022. Impact of ZNF804A rs1344706 or CACNA1C rs1006737 polymorphisms on cognition in patients with severe mental disorders: A systematic review and meta-analysis. In The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 24, 195-208. doi:10.1080/15622975.2022.2097308. https://pubmed.ncbi.nlm.nih.gov/35786202/
7. Chang, Xiaohan, Dong, Yunxia. 2021. CACNA1C is a prognostic predictor for patients with ovarian cancer. In Journal of ovarian research, 14, 88. doi:10.1186/s13048-021-00830-z. https://pubmed.ncbi.nlm.nih.gov/34210324/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen